These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35777873)

  • 21. Pharmacovigilance of suspected or confirmed therapeutic ineffectiveness of artemisinin-based combination therapy: extent, associated factors, challenges and solutions to reporting.
    Kiguba R; Ndagije HB; Nambasa V; Manirakiza L; Kirabira E; Serwanga A; Olsson S; Speybroeck N; Mukonzo J
    Malar J; 2020 Nov; 19(1):389. PubMed ID: 33143714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.
    Semitala FC; Kadota JL; Musinguzi A; Welishe F; Nakitende A; Akello L; Kunihira Tinka L; Nakimuli J; Ritar Kasidi J; Bishop O; Nakasendwa S; Baik Y; Patel D; Sammann A; Nahid P; Belknap R; Kamya MR; Handley MA; Phillips PP; Katahoire A; Berger CA; Kiwanuka N; Katamba A; Dowdy DW; Cattamanchi A
    PLoS Med; 2024 Feb; 21(2):e1004356. PubMed ID: 38377166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing a norming intervention to promote acceptance of HIV testing and reduce stigma during household tuberculosis contact investigation: protocol for a cluster-randomised trial.
    Armstrong-Hough M; Ggita J; Gupta AJ; Shelby T; Nangendo J; Ayen DO; Davis JL; Katamba A
    BMJ Open; 2022 May; 12(5):e061508. PubMed ID: 35613785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Todurujo na Kadurok (empowering youth): study protocol of an HIV self-testing and edutainment comic cluster randomised trial among refugee youth in a humanitarian setting in Uganda.
    Logie CH; Okumu M; Loutet MG; Coelho M; Berry I; Gittings L; Odong Lukone S; Kisubi N; Atama M; Kyambadde P
    BMJ Open; 2022 Nov; 12(11):e065452. PubMed ID: 36418143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study protocol for the SMART2D adaptive implementation trial: a cluster randomised trial comparing facility-only care with integrated facility and community care to improve type 2 diabetes outcomes in Uganda, South Africa and Sweden.
    Guwatudde D; Absetz P; Delobelle P; Östenson CG; Olmen Van J; Alvesson HM; Mayega RW; Ekirapa Kiracho E; Kiguli J; Sundberg CJ; Sanders D; Tomson G; Puoane T; Peterson S; Daivadanam M;
    BMJ Open; 2018 Mar; 8(3):e019981. PubMed ID: 29550780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
    McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
    Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mobile apps for quick adverse drug reaction report: A scoping review.
    Parracha ER; Advinha AM; Lopes MJ; Oliveira-Martins S
    Pharmacoepidemiol Drug Saf; 2023 Jan; 32(1):19-27. PubMed ID: 36125022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes.
    Bardon AR; Dorward J; Sookrajh Y; Sayed F; Quame-Amaglo J; Pillay C; Feutz E; Ngobese H; Simoni JM; Sharma M; Cressey TR; Gandhi M; Lessells R; Moodley P; Naicker N; Naidoo K; Thomas K; Celum C; Abdool Karim S; Garrett N; Drain PK
    BMJ Open; 2021 Oct; 11(10):e050116. PubMed ID: 34610939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Advanced Technologies Supplemented with Traditional Methods in Pharmacovigilance Sciences.
    Satwika MV; Sushma DS; Jaiswal V; Asha S; Pal T
    Recent Pat Biotechnol; 2021; 15(1):34-50. PubMed ID: 33087036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Retrospective Review of Serious Adverse Drug Reaction Reports in the Nigerian VigiFlow Database from September 2004 to December 2016.
    Ogar CK; Abiola A; Yuah D; Ibrahim A; Oreagba IA; Amadi EC; Adeyeye MC; Oshikoya KA
    Pharmaceut Med; 2019 Apr; 33(2):145-157. PubMed ID: 31933250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted spontaneous reporting of suspected renal toxicity in patients undergoing highly active anti-retroviral therapy in two public health facilities in Uganda.
    Ndagije H; Nambasa V; Namagala E; Nassali H; Kajungu D; Sematiko G; Olsson S; Pal S
    Drug Saf; 2015 Apr; 38(4):395-408. PubMed ID: 25749663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the factors and barriers of healthcare professionals in tertiary care hospitals toward pharmacovigilance: a multicenter study from Khyber Pakhtunkhwa, Pakistan.
    Sharif MJH; Farrukh MJ; Khan FU; Khan Q; Ahmed SS; Kousar R; Ahmad T; Abid SMA; Ashfaq M; Khan SA
    Curr Med Res Opin; 2022 Apr; 38(4):595-605. PubMed ID: 35166143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mobile Health-Supported Virtual Reality and Group Problem Management Plus: Protocol for a Cluster Randomized Trial Among Urban Refugee and Displaced Youth in Kampala, Uganda (Tushirikiane4MH, Supporting Each Other for Mental Health).
    Logie CH; Okumu M; Kortenaar JL; Gittings L; Khan N; Hakiza R; Kibuuka Musoke D; Nakitende A; Katisi B; Kyambadde P; Khan T; Lester R; Mbuagbaw L
    JMIR Res Protoc; 2022 Dec; 11(12):e42342. PubMed ID: 36480274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current Scenario and Future Prospects of Adverse Drug Reactions (ADRs) Monitoring and Reporting Mechanisms in the Rural Areas of India.
    Shukla S; Sharma P; Gupta P; Pandey S; Agrawal R; Rathour D; Kumar Kewat D; Singh R; Kumar Thakur S; Paliwal R; Sulakhiya K
    Curr Drug Saf; 2024; 19(2):172-190. PubMed ID: 37132145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Burden of Adverse Drug Reactions to Isoniazid Preventive Therapy in People Living With HIV at 3 Tertiary Hospitals in Uganda: Associated Factors.
    Nanyonga SM; Kitutu FE; Kalyango J; Frank M; Kiguba R
    J Acquir Immune Defic Syndr; 2022 Feb; 89(2):215-221. PubMed ID: 34693930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study protocol and implementation details for a pragmatic, stepped-wedge cluster randomised trial of a digital adherence technology to facilitate tuberculosis treatment completion.
    Crowder R; Kityamuwesi A; Kiwanuka N; Lamunu M; Namale C; Tinka LK; Nakate AS; Ggita J; Turimumahoro P; Babirye D; Oyuku D; Berger CA; Tucker A; Patel D; Sammann A; Dowdy D; Stavia T; Cattamanchi A; Katamba A
    BMJ Open; 2020 Nov; 10(11):e039895. PubMed ID: 33247012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hospital admissions attributed to adverse drug reactions in tertiary care in Uganda: burden and contributing factors.
    Asio L; Nasasira M; Kiguba R
    Ther Adv Drug Saf; 2023; 14():20420986231188842. PubMed ID: 37529762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.